These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32449861)

  • 1. Identification of amyloid antibodies for Alzheimer disease - immunotherapy.
    Huwait EA; Baghallab IM; Glabe CG; Abulnaja KO; Kumosani TA; Moselhy SS
    Arch Physiol Biochem; 2022 Oct; 128(5):1275-1282. PubMed ID: 32449861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An "epitomic" analysis of the specificity of conformation-dependent, anti-Aß amyloid monoclonal antibodies.
    Reyes-Ruiz JM; Nakajima R; Baghallab I; Goldschmidt L; Sosna J; Mai Ho PN; Kumosani T; Felgner PL; Glabe C
    J Biol Chem; 2021; 296():100168. PubMed ID: 33298522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.
    Baghallab I; Reyes-Ruiz JM; Abulnaja K; Huwait E; Glabe C
    J Alzheimers Dis; 2018; 66(3):1235-1244. PubMed ID: 30412489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain.
    Hatami A; Albay R; Monjazeb S; Milton S; Glabe C
    J Biol Chem; 2014 Nov; 289(46):32131-32143. PubMed ID: 25281743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell.
    Matsunaga Y; Saito N; Fujii A; Yokotani J; Takakura T; Nishimura T; Esaki H; Yamada T
    Biochem J; 2002 Feb; 361(Pt 3):547-56. PubMed ID: 11802784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.
    Hatami A; Monjazeb S; Glabe C
    J Alzheimers Dis; 2016; 50(2):517-25. PubMed ID: 26682688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.
    Ramakrishnan M; Kandimalla KK; Wengenack TM; Howell KG; Poduslo JF
    Biochemistry; 2009 Nov; 48(43):10405-15. PubMed ID: 19775170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the β-amyloid(4-10) epitope of plaque specific Aβ antibodies by affinity-mass spectrometry using alanine site mutation.
    Ștefănescu R; Lupu L; Manea M; Iacob RE; Przybylski M
    J Pept Sci; 2018 Jan; 24(1):. PubMed ID: 29322650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
    Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
    BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication.
    Munke A; Persson J; Weiffert T; De Genst E; Meisl G; Arosio P; Carnerup A; Dobson CM; Vendruscolo M; Knowles TPJ; Linse S
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6444-6449. PubMed ID: 28584111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid β 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Acero G; Garay C; Venegas D; Ortega E; Gevorkian G
    Neurosci Lett; 2020 Apr; 724():134876. PubMed ID: 32114116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of anti-beta-amyloid antibodies via phage display technology.
    Frenkel D; Dori M; Solomon B
    Vaccine; 2004 Jun; 22(19):2505-8. PubMed ID: 15193416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and brain delivery of anti-aggregating antibodies against beta-amyloid plaques using phage display technology.
    Solomon B; Frenkel D
    J Neural Transm Suppl; 2002; (62):321-5. PubMed ID: 12456075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.
    Bai J; Li X; Zhao J; Zong H; Yuan Y; Wang L; Zhang X; Ke Y; Han L; Xu J; Ma B; Zhang B; Zhu J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
    J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
    Kang CK; Jayasinha V; Martin PT
    Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.
    Cehlar O; Skrabana R; Revajova V; Novak M
    Bratisl Lek Listy; 2018; 119(4):201-204. PubMed ID: 29663816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope structure and binding affinity of single chain llama anti-β-amyloid antibodies revealed by proteolytic excision affinity-mass spectrometry.
    Paraschiv G; Vincke C; Czaplewska P; Manea M; Muyldermans S; Przybylski M
    J Mol Recognit; 2013 Jan; 26(1):1-9. PubMed ID: 23280612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.